Pathophysiology of Alzheimer Disease: Current Drug Therapy
Book:
Frontiers in Clinical Drug Research - Alzheimer Disorders
Page:
87-109
Author(s):
Sumeet Gupta and Vikas Jhawat
Retinal Neurodegeneration in Alzheimer’s Disease
Book:
Frontiers in Clinical Drug Research - Alzheimer Disorders
Page:
56-86
Author(s):
L. Guo, M. Pahlitzsch, F. Javaid and M. F. Cordeiro
Stem Cell Strategies for the Modeling and Therapy of Alzheimer’s Disease
Book:
Frontiers in Clinical Drug Research - Alzheimer Disorders
Page:
20-55
Author(s):
Haigang Gu
Pharmacologic Obesity Treatment – Emphasis on Efficacy and Cardiometabolic Markers
Book:
Frontiers in Clinical Drug Research-Diabetes and Obesity
Page:
1-19
Author(s):
Fariha Salman, Ivan Gerling and Helmut O. Steinberg
Functional Validation of Drug Nanoconjugates in vivo
Book:
Frontiers in Nanomedicine
Page:
184-198
Author(s):
Ibane Abasolo, Yolanda Fernández and Simó Schwartz
Neuronopathic LSDs: Quest for Treatments Drives Research in Nanomedicine and Nanotechnology
Book:
Frontiers in Nanomedicine
Page:
128-155
Author(s):
Cinzia M. Bellettato, David J. Begley, Christina Lampe and Maurizio Scarpa
Nanoparticles Targeting Mitochondria in Neurodegenerative Diseases: Toxicity and Challenge for Nanotherapeutics
Book:
Frontiers in Nanomedicine
Page:
61-100
Author(s):
Michal Cagalinec
Nanomedicine and Neurodegenerative Diseases: An Introduction to Pathology and Drug Targets
Book:
Frontiers in Nanomedicine
Page:
1-60
Author(s):
Tasnuva Sarowar and Andreas M. Grabrucker
Shared Pathophysiology between Depression, Obesity and Metabolic Disturbances: Novel Antidepressant Targets?
Book:
Frontiers in Drug Discovery
Page:
298-356
Author(s):
Léa Décarie-Spain, Dominique Matthys and Stephanie E. Fulton
The Relevance of Studies in Healthy Human Volunteers for The Development of Novel Antidepressants: Exploring Endophenotypes
Book:
Frontiers in Drug Discovery
Page:
99-125
Author(s):
Renato T. Ramos